Ascendis Pharma A/S
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
311.13 |
705.50 |
1,272.63 |
1,966.15 |
2,716.04 |
3,332.90 |
| Przychód Δ r/r |
0.00% |
126.75% |
80.39% |
54.49% |
38.14% |
22.71% |
| Przychód (min) |
268.29 |
596.77 |
949.03 |
1,547.27 |
2,137.40 |
2,622.83 |
| Przychód (max) |
379.42 |
997.43 |
1,735.21 |
2,631.87 |
3,635.68 |
4,461.39 |
| EBITDA (średnia) |
-298.54 |
-676.94 |
-1,221.10 |
-1,886.54 |
-2,606.07 |
-3,197.95 |
| EBIT (średnia) |
-301.57 |
-683.81 |
-1,233.50 |
-1,905.70 |
-2,632.53 |
-3,230.42 |
| EBIT % |
-96.93% |
-96.93% |
-96.93% |
-96.93% |
-96.93% |
-96.93% |
| Zysk netto (średni) |
-386.08 |
-250.88 |
157.12 |
598.30 |
938.33 |
1,275.22 |
| Zysk netto % |
-124.09% |
-35.56% |
12.35% |
30.43% |
34.55% |
38.26% |
| EPS (średnia) |
-6.84 |
-4.33 |
2.16 |
9.90 |
16.21 |
22.03 |
| Liczba analityków (Przychody) |
10 |
11 |
15 |
11 |
4 |
5 |
| Liczba analityków (EPS) |
10 |
11 |
11 |
7 |
5 |
2 |
| symbol |
ASND |
ASND |
ASND |
ASND |
ASND |
ASND |